Clinical significance of apoptotic index in non-small cell lung cancer: Correlation with p53, mdm2, pRb and p21WAF1/CIP1 protein expression

Journal of Cancer Research and Clinical Oncology

Volumn 131, Issue 9, 2005, Pages 617-623

  Dworakowska, D ^a   Jassem, E ^a   Jassem, J ^a   Karmolinski A ^a   Dworakowski, R ^a   Wirth, T ^b   Gruchala M ^a   Rynkiewicz, A ^a   Skokowski, J ^a   Yla Herttuala, S ^b   Jaskiewicz K ^a   Czestochowska E ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

AI; mdm2; NSCLC; p21WAF1 CIP1; p53; pRb

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; PROTEIN MDM2; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL;

AGED; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MDM2; RETINOBLASTOMA PROTEIN; SURVIVAL ANALYSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 27644493159     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-005-0010-7     Document Type: Article

References (25)

1. el-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54:1169-1174
2. Hanaoka T, Nakayama J, Haniuda M, Sato TA (2002) Immunohistochemical demonstration of apoptosis-regulated proteins, Bcl-2 and Bax, in resected non-small-cell lung cancers. Int J Clin Oncol 7:152-158
3. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816
4. Harris CC (1996) Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 88:1442-1455
5. Hsieh JK, Chan FS, O'Connor DJ, Mittnacht S, Zhong S, Lu X (1999) RB regulates the stability and the apoptotic function of p53 via MDM2. Mol Cell 3:181-193
6. Kerr JFR, Winterford CM, Harmon BV (1994) Apoptosis: its significance in cancer and cancer therapy. Cancer 73:2013-2026
7. Kotelnikov VM, Coon JS, Mundle S, Kelanic S, La Follette S, Taylor S IV, Hutchinson J, Panje W, Caldarelli DD, Preisler HD (1997) Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis. Clin Cancer Res 3:95-101
8. Lane DP (1992) Cancer. p53, guardian of the genome. Nature 358:15-16
9. Langendijk H, Thunnissen E, Arends JW, de Jong J, ten Velde G, Lamers R, Guinee D, Holden J, Wouters M (2000) Cell proliferation and apoptosis in stage III inoperable non-small cell lung carcinoma treated by radiotherapy. Radiother Oncol 56:197-207
10. Levine AJ, Momand J, Finlay CA (1991) The p53 tumour suppressor gene. Nature 351:453-456
11. Li R, Waga S, Hannon GJ, Beach D, Stillman B (1994) Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371:534-537
12. Macluskey M, Baillie R, Chandrachud LM, Pendleton N, Schor AM (2000) High levels of apoptosis are associated with improved survival in non-small cell lung cancer. Anticancer Res 20:2123-2128
13. Matturri L, Colombo B, Lavezzi AM (1999) Evidence for apoptosis in non-small cell lung carcinoma. Relationship with cell kinetics and prognosis. Anal Quant Cytol Histol 21:240-244
14. Momand J, Zambetti GP (1997) Mdm2: "Big Brother" of p53. J Cell Biochem 64:343-352
15. Piette J, Neel H, Marechal V (1997) Mdm2: keeping p53 under control. Oncogene 15:1001-1010
16. Prives C, Hall PA (1999) The p53 pathway. J Pathol 187:112-126
17. Puglisi F, Minisini AM, Aprile G, Barbone F, Cataldi P, Artico D, Damante G, Beltrami CA, Di Loreto C (2002) Balance between cell division and cell death as predictor of survival in patients with non-small-cell lung cancer. Oncology 63:76-83
18. Pulkkanen KJ, Laukkanen MO, Naarala J, Yla-Herttuala S (2000) False-positive apoptosis signal in mouse kidney and liver detected with TUNEL assay. Apoptosis 5:329-333
19. Roninson IB (2002) Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 179:1-14
20. Shiina H, Igawa M, Shigeno K, Yamasaki Y, Urakami S, Yoneda T, Wada Nagasaki, Honda S, Nagasaki M (1999) Clinical significance of mdm2 and p53 expression in bladder cancer. A comparison with cell proliferation and apoptosis. Oncology 56:239-247
21. Sobin LH, Wittekind C (1997) TNM classification of malignant tumors. UICC International Union Against Cancer. Wiley-Liss, New York
22. Soini Y, Pääkkö P, Lehto VP (1998) Histopathological evaluation of apoptosis in cancer. Am J Pathol 153:1041-1053
23. Tanaka F, Takata T, Yamada T, Yanagihara K, Otake Y, Miyahara R, Nakagawa T, Kawano Y, Ishikawa S, Inui K, Wada H (2002) Apoptotic tumor-cell death in response to cell proliferation is influenced by p53 status in resected non-small cell lung cancer. Lung Cancer 36:27-32
24. Törmänen U, Eerola AK, Rainio P, Vähäkangas K, Soini Y, Sormunen R, Bloigu R, Lehto VP, Paakko P (1995) Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res 55:5595-5602
25. Yap DB, Hsieh JK, Chan FS, Lu X (1999) mdm2: a bridge over the two tumour suppressors, p53 and Rb. Oncogene 18:7681-7689